scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Rosario Donato | |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 540-51 | |
P577 | publication date | 2003-04-15 | |
P1433 | published in | Microscopy Research and Technique | Q59757 |
P1476 | title | Intracellular and extracellular roles of S100 proteins | |
P478 | volume | 60 |
Q37691627 | 12-O-tetradecanoylphorbol-13-acetate promotes breast cancer cell motility by increasing S100A14 level in a Kruppel-like transcription factor 4 (KLF4)-dependent manner |
Q61444602 | 5-Fluorouracil Induces Enteric Neuron Death and Glial Activation During Intestinal Mucositis via a S100B-RAGE-NFκB-Dependent Pathway |
Q42426738 | A Comparison of the Dynamics of S100B, S100A1, and S100A6 mRNA Expression in Hippocampal CA1 Area of Rats during Long-Term Potentiation and after Low-Frequency Stimulation |
Q50940723 | A Seasonal and Age-Related Study of Interstitial Cells in the Pineal Gland of Male Viscacha (Lagostomus maximus maximus). |
Q93016458 | A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection |
Q49089385 | A comparison of two different assays for determining S-100B in serum and urine |
Q35984262 | A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children. |
Q91724453 | A new approach to discovery of S100 protein heterodimers |
Q37590627 | A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury |
Q34688627 | A systematic review of the biomarker S100B: implications for sport-related concussion management |
Q42468514 | Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosis |
Q38983986 | Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells |
Q55045593 | Allogenic Adipose Derived Stem Cells Transplantation Improved Sciatic Nerve Regeneration in Rats: Autologous Nerve Graft Model. |
Q28553734 | Amlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell Proliferation |
Q41844120 | An efficient expression and purification strategy for the production of S100 proteins in Escherichia coli |
Q41683145 | An efficient method for the preparation of preferentially heterodimerized recombinant S100A8/A9 coexpressed in Escherichia coli |
Q42460134 | An immunohistochemical observations on the oviduct of the goat |
Q38258912 | Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation. |
Q37164099 | Annexin I and annexin II N-terminal peptides binding to S100 protein family members: specificity and thermodynamic characterization |
Q39212411 | Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. |
Q33724276 | Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model |
Q48359189 | Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat. |
Q88674963 | Association between serum S100A1 level and Global Registry of Acute Coronary Events score in patients with non-ST-segment elevation acute coronary syndrome |
Q48225316 | Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis |
Q39181656 | Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders |
Q46135507 | Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings |
Q34944470 | Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury |
Q37694734 | Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers |
Q48411119 | Axo-somatic inhibition of projection neurons in the lateral nucleus of amygdala in human temporal lobe epilepsy: an ultrastructural study |
Q24657552 | Azaspiracid shellfish poisoning: a review on the chemistry, ecology, and toxicology with an emphasis on human health impacts |
Q33847222 | Baicalin promotes the viability of Schwann cells in vitro by regulating neurotrophic factors |
Q28078688 | Binding of transition metals to S100 proteins |
Q34680228 | Binge alcohol alters exercise-driven neuroplasticity. |
Q37207351 | Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future. |
Q36052700 | Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine |
Q33746983 | Biomarkers of inflammatory bowel disease |
Q28553904 | Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast |
Q24318378 | Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function |
Q41775044 | Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals |
Q42738033 | Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes |
Q50086078 | Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left-Sided Colon Cancer |
Q37097531 | Calcium-binding S100 protein expression in pterygium |
Q57154332 | Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) |
Q50004471 | Calprotectin and the Initiation and Progression of Head and Neck Cancer |
Q47306233 | Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate |
Q53803699 | Calprotectin is released from human skeletal muscle tissue during exercise. |
Q37825812 | Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease |
Q28296403 | Cardiac adenoviral S100A1 gene delivery rescues failing myocardium |
Q38506250 | Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology |
Q51706020 | Cellular Distribution and Gene Expression Pattern of Metastasin (S100A4), Calgranulin A (S100A8), and Calgranulin B (S100A9) in Oral Lesions as Markers for Molecular Pathology. |
Q37186176 | Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse |
Q53347703 | Changes in CNS cells in hyperammonemic portal hypertensive rats. |
Q48682863 | Characterization of S100A11, a suppressive factor of fertilization, in the mouse female reproductive tract |
Q24310573 | Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15 |
Q37187661 | Chronic fluoxetine treatment changes S100B expression during postnatal rat brain development |
Q48786828 | Cloning and characterization of Xenopus dicalcin, a novel S100-like calcium-binding protein in Xenopus eggs |
Q39733928 | Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma |
Q34027220 | Comparative 2D-DIGE proteomic analysis of bovine mammary epithelial cells during lactation reveals protein signatures for lactation persistency and milk yield |
Q35925645 | Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization |
Q37602130 | Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease |
Q27652075 | Crystal Structure of Metastasis-Associated Protein S100A4 in the Active Calcium-Bound Form |
Q46032511 | Curcumin upregulates S100 expression and improves regeneration of the sciatic nerve following its complete amputation in mice. |
Q64930555 | Current Landscape of Heart Failure Gene Therapy. |
Q24295245 | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B |
Q24600574 | Current status of biomarkers for prostate cancer |
Q33958590 | Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA |
Q36282224 | Cytokinesis is not controlled by calmodulin or myosin light chain kinase in the Caenorhabditis elegans early embryo |
Q42722989 | Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. |
Q35617658 | Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. |
Q42032160 | Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction. |
Q38347685 | Development of the olfactory bulbs in human fetuses (an immunohistochemical study). |
Q30433016 | Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation |
Q33862470 | Diagnostic and prognostic biomarkers in melanoma |
Q40632668 | Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma. |
Q51596002 | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer. |
Q48603300 | Diagnostic value of S100B protein in the differential diagnosis of acute vertigo in the emergency department. |
Q38345582 | Dicalcin inhibits fertilization through its binding to a glycoprotein in the egg envelope in Xenopus laevis |
Q39630655 | Differences between Mycobacterium-Host Cell Relationships in Latent Tuberculous Infection of Mice Ex Vivo and Mycobacterial Infection of Mouse Cells In Vitro |
Q36594528 | Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases |
Q82929527 | Differential bulbar and extrabulbar projections of diverse olfactory receptor neuron populations in the adult zebrafish (Danio rerio) |
Q81663557 | Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease |
Q34284848 | Differential occurrence of S100A7 in breast cancer tissues: a proteomic-based investigation. |
Q35190059 | Differential temporal expression of S100β in developing rat brain |
Q31112256 | Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors |
Q48169734 | Distinctive effects of unpredictable subchronic stress on memory, serum corticosterone and hippocampal BDNF levels in high and low exploratory mice |
Q27651040 | Divalent Metal Ion Complexes of S100B in the Absence and Presence of Pentamidine |
Q26797413 | Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes |
Q64984123 | Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice. |
Q38952277 | Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer |
Q33585802 | Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses |
Q24300783 | Effect of Human S100A13 Gene Silencing on FGF-1 Transportation in Human Endothelial Cells |
Q64963332 | Effect of calprotectin subunit S100A9 on the expression and methylation of OCLN in human melanoma cell line A-375. |
Q35702968 | Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models |
Q44983633 | Effect of the PARP-1 inhibitor PJ 34 on excitotoxic damage evoked by kainate on rat spinal cord organotypic slices |
Q42431184 | Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model |
Q51038904 | Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. |
Q37439430 | Embryonic development of glial cells and myelin in the shark, Chiloscyllium punctatum |
Q90182627 | Engraftment potential of maternal adipose-derived stem cells for fetal transplantation |
Q38836943 | Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes |
Q24314713 | Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein |
Q36610866 | Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma |
Q60949926 | Evaluation of NSE and S100B in patients with tick-borne encephalitis |
Q36038810 | Evaluation of Pre-Treatment and Post-Treatment S100B, Oxidant and Antioxidant Capacity in Children with Diabetic Ketoacidosis. |
Q54309049 | Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. |
Q37697035 | Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53. |
Q35041490 | Expressed sequence tags for bovine muscle satellite cells, myotube formed-cells and adipocyte-like cells |
Q47631836 | Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma |
Q36601694 | Expression of S100B during the innate immune of corneal epithelium against fungi invasion |
Q34074109 | Expression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinoma |
Q34591271 | Expression of receptor for advanced glycation end products in sarcoid granulomas. |
Q24297169 | Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation |
Q64086388 | Expression profile and functional role of S100A14 in human cancer |
Q28205358 | Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2) |
Q47662103 | Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity |
Q27021773 | Fecal biomarkers of intestinal health and disease in children |
Q87285223 | Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD |
Q33294429 | Fragment docking to S100 proteins reveals a wide diversity of weak interaction sites. |
Q27658965 | Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands |
Q40572870 | Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay |
Q33818667 | Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome |
Q47259842 | Gene expression changes in the course of neural progenitor cell differentiation. |
Q24314913 | Gene from a psoriasis susceptibility locus primes the skin for inflammation |
Q27312010 | Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients |
Q59789698 | Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis |
Q38333462 | Glucocorticoid receptor-mediated transcriptional activation of S100P gene coding for cancer-related calcium-binding protein. |
Q36842403 | Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis |
Q38782492 | Hippocampal Astrocyte Cultures from Adult and Aged Rats Reproduce Changes in Glial Functionality Observed in the Aging Brain |
Q35404108 | How does extracerebral trauma affect the clinical value of S100B measurements? |
Q24336365 | Human S100A12: a novel key player in inflammation? |
Q34647617 | Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium |
Q43699250 | Human skin transcriptome during superficial cutaneous wound healing. |
Q40098520 | Hypomethylation-induced expression of S100A4 in endometrial carcinoma |
Q97646186 | Identification of Prognostic Immune-Related Genes by Integrating mRNA Expression and Methylation in Lung Adenocarcinoma |
Q33526078 | Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer |
Q33267758 | Identification of a novel interaction between the Ca(2+)-binding protein S100A11 and the Ca(2+)- and phospholipid-binding protein annexin A6. |
Q39496829 | Identification of differentially expressed genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human bronchial epithelial cells |
Q35865646 | Immunohistochemical Characterization of S100A6 in the Murine Ovary |
Q34949342 | Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assay |
Q43182019 | In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form. |
Q42414162 | Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products |
Q48540011 | Increased serum levels of the brain damage marker S100B after apnea in trained breath-hold divers: a study including respiratory and cardiovascular observations |
Q37705110 | Inflammation-associated S100 proteins: new mechanisms that regulate function. |
Q48907818 | Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism |
Q42185907 | Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain |
Q50571921 | Interplay of proliferation and differentiation factors is revealed in the early human eye development. |
Q42579440 | Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease |
Q34852178 | Intricacies of redoxome function demonstrated with a simple in vitro chemiluminescence method, with special reference to vitamin B12 as antioxidant |
Q41890417 | Isolated vertebral fractures give elevated serum protein S-100B levels |
Q38118075 | Joining S100 proteins and migration: for better or for worse, in sickness and in health. |
Q36092488 | Keratin and S100 calcium-binding proteins are major constituents of the bovine teat canal lining. |
Q42450906 | Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction |
Q33683985 | Large-scale proteomic identification of S100 proteins in breast cancer tissues |
Q56992670 | Longitudinal serum S100β and brain aging in the Lothian Birth Cohort 1936 |
Q84984868 | Loss of Arnt (Hif1β) in mouse epidermis triggers dermal angiogenesis, blood vessel dilation and clotting defects |
Q36308264 | Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. |
Q47127034 | MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles |
Q48483209 | MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions. |
Q36617801 | MRP8/14 enhances corneal susceptibility to Pseudomonas aeruginosa Infection by amplifying inflammatory responses. |
Q38009240 | Macrophage-related diseases of the gut: a pathologist's perspective |
Q43262776 | Mechanism of S100b release from rat cortical slices determined under basal and stimulated conditions |
Q34512645 | Mechanism of the Ca²+-dependent interaction between S100A4 and tail fragments of nonmuscle myosin heavy chain IIA. |
Q33383191 | Mecp2-null mice provide new neuronal targets for Rett syndrome. |
Q28575948 | Metastasis-associated S100A4 (Mts1) protein is expressed in subpopulations of sensory and autonomic neurons and in Schwann cells of the adult rat |
Q44918219 | Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. |
Q39911288 | Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype |
Q42285471 | Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers |
Q38492052 | Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy |
Q47612069 | Molecular analysis of transitional cell carcinoma using cDNA microarray |
Q43768901 | Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73. |
Q34698701 | Molecular determinants of S100B oligomer formation |
Q45124518 | Molecular evolution of a novel marsupial S100 protein (S100A19) which is expressed at specific stages of mammary gland and gut development |
Q42151468 | Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein |
Q36456638 | Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. |
Q88956893 | Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology |
Q36169181 | Multiple Evolutionary Origins of Ubiquitous Cu2+ and Zn2+ Binding in the S100 Protein Family |
Q24650933 | Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ... |
Q35558302 | Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9. |
Q41396881 | Nerve guidance conduits based on double-layered scaffolds of electrospun nanofibers for repairing the peripheral nervous system |
Q46302002 | Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. |
Q38162092 | Neurological damage in MSUD: the role of oxidative stress. |
Q51835366 | Neuronal and glial differentiation during lizard (Gallotia galloti) visual system ontogeny. |
Q36102944 | Neuropsychopharmacological understanding for therapeutic application of morphinans |
Q30862375 | New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis |
Q38186720 | Nonclassically Secreted Regulators of Angiogenesis |
Q28286769 | Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function |
Q28568022 | Novel interaction of the dopamine D2 receptor and the Ca2+ binding protein S100B: role in D2 receptor function |
Q42128457 | Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization |
Q33651153 | Nuclear S100A7 is associated with poor prognosis in head and neck cancer. |
Q35905318 | Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface. |
Q38105784 | Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis. |
Q54405936 | Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis. |
Q34578962 | Overexpression of S100A4 as a biomarker of metastasis and recurrence in oral squamous cell carcinoma |
Q30984031 | Overexpression of S100A4 in human cancer cell lines resistant to methotrexate |
Q37399800 | Oxidative modifications of S100 proteins: functional regulation by redox |
Q38792223 | PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair |
Q40458081 | Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice. |
Q36499886 | Peripheral blood gene expression profiling for cardiovascular disease assessment |
Q28305819 | Peripheral nerve regeneration using autologous porcine skin-derived mesenchymal stem cells |
Q38211488 | Pharmacology of intra-articular triamcinolone |
Q92519199 | Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody |
Q48824406 | Postnatal developmental profile of neurons and glia in motor nuclei of the brainstem and spinal cord, and its comparison with organotypic slice cultures |
Q38812245 | Pro-neurogenic effect of β-asarone on RSC96 Schwann cells in vitro. |
Q57976328 | Probing the interaction of distamycin A with S100β: the “unexpected” ability of S100β to bind to DNA-binding ligands |
Q33296143 | Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry |
Q50543875 | Prognostic impact of S100A9 overexpression in non-small cell lung cancer. |
Q48089252 | Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer |
Q36425962 | Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma |
Q33783947 | Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells |
Q61855549 | Protein expression patterns associated with advanced stage ovarian cancer |
Q33891766 | Protein signatures for survival and recurrence in metastatic melanoma |
Q38080394 | Protein-phospholipid interactions in nonclassical protein secretion: problem and methods of study. |
Q58726328 | Proteome analysis reveals a role of rainbow trout lymphoid organs during Yersinia ruckeri infection process |
Q28071331 | Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma |
Q42702837 | Proteomic analysis of purified coronavirus infectious bronchitis virus particles |
Q36471128 | Proteomic analysis reveals the deregulation of inflammation-related proteins in acupuncture-treated rats with asthma onset |
Q33255758 | Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages |
Q38448646 | Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes |
Q37297414 | Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro |
Q37152947 | RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. |
Q37274344 | RAGE and its ligands in bone metabolism. |
Q37018247 | Rat retinal transcriptome: effects of aging and AMD-like retinopathy |
Q40020050 | Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. |
Q34687465 | Relating form and function of EF-hand calcium binding proteins |
Q35606748 | Release of FGF1 and p40 synaptotagmin 1 correlates with their membrane destabilizing ability |
Q34503321 | Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder |
Q22252919 | Retinoids for treatment of Alzheimer's disease |
Q51987375 | Role of Scarf and its binding target proteins in epidermal calcium homeostasis. |
Q53276425 | S-100B in Serum and Urine After Traumatic Head Injury in Children |
Q49497885 | S100 Proteins As an Important Regulator of Macrophage Inflammation. |
Q35911792 | S100 calcium binding proteins and ion channels |
Q43245445 | S100 protein family and its application in clinical practice |
Q37650123 | S100 protein family in human cancer |
Q38127260 | S100 proteins and the skin: a review |
Q34337425 | S100 proteins and their influence on pro-survival pathways in cancer |
Q58086680 | S100 proteins as therapeutic targets |
Q35803078 | S100 proteins in cartilage: role in arthritis |
Q90747880 | S100 proteins in rheumatic diseases |
Q24336983 | S100 proteins interact with the N-terminal domain of MDM2 |
Q37270778 | S100-annexin complexes--biology of conditional association |
Q28249115 | S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy |
Q39130164 | S100A10 as a novel biomarker in colorectal cancer |
Q41211662 | S100A11 is a potential prognostic marker for clear cell renal cell carcinoma |
Q36325990 | S100A11, an dual mediator for growth regulation of human keratinocytes |
Q90411342 | S100A12 in Digestive Diseases and Health: A Scoping Review |
Q38059248 | S100A12: a noninvasive marker of inflammation in inflammatory bowel disease |
Q21135467 | S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE) |
Q47849319 | S100A16 is a prognostic marker for colorectal cancer. |
Q64110775 | S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway |
Q24306405 | S100A16, a novel calcium-binding protein of the EF-hand superfamily |
Q28288362 | S100A1: a multifaceted therapeutic target in cardiovascular disease |
Q36801998 | S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance |
Q33757903 | S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function |
Q52027067 | S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. |
Q37762477 | S100A2 in cancerogenesis: a friend or a foe? |
Q37620665 | S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability |
Q37461400 | S100A2 level changes are related to human periodontitis |
Q38215158 | S100A2 protein and non-small cell lung cancer. The dual role concept. |
Q33597019 | S100A4 and metastasis: a small actor playing many roles |
Q57072975 | S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue |
Q64256146 | S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain |
Q42955189 | S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. |
Q37281646 | S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling |
Q42620108 | S100A4 protects the myocardium against ischemic stress |
Q38338396 | S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors |
Q22000741 | S100A7 and the progression of breast cancer |
Q33648661 | S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells |
Q42225284 | S100A7 promotes the migration and invasion of osteosarcoma cells via the receptor for advanced glycation end products |
Q34412828 | S100A8 and S100A9 Positive Cells in Colorectal Carcinoma: Clinicopathological Analysis. |
Q34700918 | S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway |
Q46745779 | S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. |
Q39767672 | S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells |
Q58707556 | S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy |
Q37629632 | S100A8/A9: a mediator of severe asthma pathogenesis and morbidity? |
Q42483466 | S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. |
Q38160208 | S100B as a marker for brain damage and blood-brain barrier disruption following exercise |
Q92939138 | S100B as an Antagonist To Interfere with the Interface Area Flanked by S100A11 and RAGE V Domain |
Q42548561 | S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage |
Q39141087 | S100B induces the release of pro-inflammatory cytokines in alveolar type I-like cells. |
Q43284484 | S100B modulates the hemodynamic response to norepinephrine stimulation |
Q37051646 | S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages |
Q39404676 | S100B protein as a possible participant in the brain metastasis of NSCLC. |
Q48579828 | S100B protein related neonatal hypoxia |
Q90751059 | S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth |
Q45911403 | S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. |
Q37702852 | S100B: a multifunctional role in cardiovascular pathophysiology |
Q38730429 | S100B + A1 CELISA: A Novel Potency Assay and Screening Tool for Redifferentiation Stimuli of Human Articular Chondrocytes. |
Q35939963 | S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration |
Q28184570 | S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) |
Q36933470 | S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury |
Q36112314 | S100β Levels in CSF of Nonambulatory Dogs with Intervertebral Disk Disease Treated with Electroacupuncture |
Q30273961 | SOX10 transactivates S100B to suppress Schwann cell proliferation and to promote myelination |
Q52338705 | Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8/A9. |
Q24654691 | Secretion without Golgi |
Q52591318 | Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement. |
Q28079379 | Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease |
Q91615108 | Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea |
Q45023114 | Serum S100A12 levels are associated with the presence and severity of obstructive sleep apnea syndrome in male patients |
Q48437115 | Serum S100B but not NSE levels are increased in morbidly obese individuals affected by obstructive sleep apnea-hypopnea syndrome |
Q50048507 | Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis |
Q37000724 | Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy |
Q27655607 | Small Molecules Bound to Unique Sites in the Target Protein Binding Cleft of Calcium-Bound S100B As Characterized by Nuclear Magnetic Resonance and X-ray Crystallography |
Q64268568 | Solitary neurofibroma of the palate mimicking mucocele: A rare case report |
Q42107446 | Solution structure and backbone dynamics of Calsensin, an invertebrate neuronal calcium-binding protein |
Q51201229 | Solving the crystal structure of human calcium-free S100Z: the siege and conquer of one of the last S100 family strongholds. |
Q97516957 | Structural Investigation of Epididymal Microvasculature and Its Relation to Telocytes and Immune Cells in Camel |
Q24322846 | Structural and functional insights into RAGE activation by multimeric S100B |
Q27665571 | Structural characterization of human S100A16, a low-affinity calcium binder |
Q35592681 | Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex |
Q27652244 | Structure of the S100A6 Complex with a Fragment from the C-Terminal Domain of Siah-1 Interacting Protein: A Novel Mode for S100 Protein Target Recognition † ‡ |
Q37453455 | Subject-specific increases in serum S-100B distinguish sports-related concussion from sports-related exertion |
Q53278207 | TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. |
Q28259868 | Targeting S100A1 in heart failure |
Q34127542 | Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease |
Q42431159 | The Calcium-Dependent Interaction of S100B with Its Protein Targets |
Q27646625 | The Effects of CapZ Peptide (TRTK-12) Binding to S100B–Ca2+ as Examined by NMR and X-ray Crystallography |
Q37704016 | The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients |
Q48244517 | The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness |
Q34897380 | The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis |
Q42151789 | The S100B/RAGE Axis in Alzheimer's Disease |
Q33877008 | The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A. |
Q92887845 | The contribution of S100B to the glioprotective effects of valproic and arundic acids |
Q38979165 | The danger from within: alarmins in arthritis |
Q33851482 | The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation |
Q36629607 | The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma |
Q35723493 | The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis |
Q30810756 | The expression of RAGE and EN-RAGE in leprosy |
Q26851306 | The heavy chain has its day: regulation of myosin-II assembly |
Q44002553 | The impact of increased blood lactate on serum S100B and prolactin concentrations in male adult athletes |
Q38326185 | The impact of surgical timing and intervention on outcome in traumatized dogs and cats. |
Q36461096 | The ligand/RAGE axis: lighting the fuse and igniting vascular stress |
Q33343721 | The metastasis-associated protein S100A4 exists in several charged variants suggesting the presence of posttranslational modifications |
Q45368362 | The metastasis-promoting S100A4 protein confers neuroprotection in brain injury |
Q36814092 | The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis |
Q40526700 | The myeloid expressed EF-hand proteins display a diverse pattern of lipid raft association |
Q26859392 | The neuroimmunology of schizophrenia |
Q27007680 | The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis |
Q34561697 | The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? |
Q37800755 | The relevance of protein-protein interactions for p53 function: the CPE contribution. |
Q42234262 | The role of S100A12 as a systemic marker of inflammation |
Q33976905 | The role of S100A14 in epithelial ovarian tumors. |
Q34613001 | The role of TG2 in regulating S100A4-mediated mammary tumour cell migration |
Q36338158 | The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders |
Q35891644 | The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers |
Q21132534 | Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody |
Q41915588 | Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B |
Q38621771 | Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. |
Q37692260 | Transcriptional regulation and functional implication of S100P in cancer |
Q28306619 | Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense |
Q42873472 | Transient receptor potential canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and upregulates its own expression in cortical astrocytes. |
Q35582533 | Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion |
Q92058313 | Ubiquitination of Listeria Virulence Factor InlC Contributes to the Host Response to Infection |
Q38044377 | Update of faecal markers of inflammation in children with cystic fibrosis. |
Q35109940 | Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients. |
Q35715722 | Urinary FSP1 is a biomarker of crescentic GN |
Q35022269 | Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation |
Q42762235 | Voltammetric detection of S100B protein using His-tagged receptor domains for advanced glycation end products (RAGE) immobilized onto a gold electrode surface |
Q54285606 | [Analysis of the mRNA expression of the S100β protein in adipocytes of patients with diabetes mellitus, type 2]. |
Q46070291 | ¹H, ¹³C and ¹⁵N resonance assignments of Ca²⁺-bound human S100A15. |